1. Home
  2. WVE vs HLF Comparison

WVE vs HLF Comparison

Compare WVE & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • HLF
  • Stock Information
  • Founded
  • WVE 2012
  • HLF 1980
  • Country
  • WVE Singapore
  • HLF United States
  • Employees
  • WVE N/A
  • HLF N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • HLF Other Pharmaceuticals
  • Sector
  • WVE Health Care
  • HLF Health Care
  • Exchange
  • WVE Nasdaq
  • HLF Nasdaq
  • Market Cap
  • WVE 915.6M
  • HLF 877.4M
  • IPO Year
  • WVE 2015
  • HLF N/A
  • Fundamental
  • Price
  • WVE $7.79
  • HLF $8.53
  • Analyst Decision
  • WVE Strong Buy
  • HLF Strong Buy
  • Analyst Count
  • WVE 16
  • HLF 4
  • Target Price
  • WVE $20.19
  • HLF $11.50
  • AVG Volume (30 Days)
  • WVE 2.1M
  • HLF 1.2M
  • Earning Date
  • WVE 11-11-2025
  • HLF 11-05-2025
  • Dividend Yield
  • WVE N/A
  • HLF N/A
  • EPS Growth
  • WVE N/A
  • HLF 285.96
  • EPS
  • WVE N/A
  • HLF 3.17
  • Revenue
  • WVE $93,946,000.00
  • HLF $4,928,500,000.00
  • Revenue This Year
  • WVE N/A
  • HLF $1.02
  • Revenue Next Year
  • WVE $6.85
  • HLF $4.52
  • P/E Ratio
  • WVE N/A
  • HLF $2.70
  • Revenue Growth
  • WVE N/A
  • HLF N/A
  • 52 Week Low
  • WVE $5.28
  • HLF $5.04
  • 52 Week High
  • WVE $16.74
  • HLF $10.83
  • Technical
  • Relative Strength Index (RSI)
  • WVE 52.90
  • HLF 41.15
  • Support Level
  • WVE $6.91
  • HLF $8.50
  • Resistance Level
  • WVE $8.31
  • HLF $9.15
  • Average True Range (ATR)
  • WVE 0.42
  • HLF 0.34
  • MACD
  • WVE 0.15
  • HLF -0.00
  • Stochastic Oscillator
  • WVE 69.65
  • HLF 34.74

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

Share on Social Networks: